<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03180567</url>
  </required_header>
  <id_info>
    <org_study_id>Prof Amr gawaly</org_study_id>
    <nct_id>NCT03180567</nct_id>
  </id_info>
  <brief_title>Pharmacogentic Screening of Coumarine Based Oral Anticoagulant Using Next Generation Seguencer</brief_title>
  <official_title>Pharmacogentic Screening of Coumarine Based Oral Anticoagulant Using Next Generation Seguencer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tanta University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tanta University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      As drug response is a complex trait in the majority of cases using an optimal starting dose
      for an individual may reduce the time taken to reach a stable INR, and reduce the risk of
      having either a high INR (with a risk of bleeding) or a low INR (with a risk of thrombosis)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The results of this project will benefit in (1) Identification of novel features or mutation
      types in warfarin resistance genomes. (2) To determine whether other polymorphisms in
      noncoding regions or their unique haplotype combinations contribute to the variability in the
      maintenance dose of warfarin, and (3)personalization of the drug and deciding the correct
      dose from the start.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 6, 2017</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>number of patients with genetic polymorphism</measure>
    <time_frame>6 months</time_frame>
    <description>patients with abnormal polymorphisms</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Thrombosis</condition>
  <arm_group>
    <arm_group_label>Warfarin resistant patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Genetic Mutations</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Genetic Mutations</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Genetic Mutations</intervention_name>
    <description>By next generation sequencing</description>
    <arm_group_label>Warfarin resistant patients</arm_group_label>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with thrombosis and warfarin resistance

        Exclusion Criteria:

          -  less than 18 years
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Amr Gawaly, Consultant</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hematology Dept. - Tanta University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Said Hammad Abdou, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinical Pathology dept.- Tanta University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Enas Abdul-Raouf, Lecturer</last_name>
    <role>Study Director</role>
    <affiliation>Biology and Genetics- Tanta University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Abdelaziz Zidane, Lecturer</last_name>
    <role>Study Chair</role>
    <affiliation>Genetics-Damanhour University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Amr Gawaly, Ass Prof</last_name>
    <phone>01221793033</phone>
    <email>amrgawaly1@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sherief Abd-Elsalam</name>
      <address>
        <city>Cairo</city>
        <state>Tanta</state>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sherief Abd-elsalam, lecturer</last_name>
      <phone>00201000040794</phone>
      <email>Sherif_tropical@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Ahmed Elsharkawy, Ass. lect.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 6, 2017</study_first_submitted>
  <study_first_submitted_qc>June 6, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 8, 2017</study_first_posted>
  <last_update_submitted>June 6, 2017</last_update_submitted>
  <last_update_submitted_qc>June 6, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thrombosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anticoagulants</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

